Drug Development

Drug Development Market Research Report

MarketsandMarkets offers micro level research on drug development market that encompasses key markets such as pharmacokinetics, lab automation, biosensors and detection technologies, imaging technologies, microfluidics and others.

Market Reports

Title	Published	Price
Autoimmune Treatment Market (2009 - 2014) The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.	September 2009	$ 4650
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.	April 2010	$ 4650
Global Ophthalmology Drugs & Devices Market Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.	May 2010	$ 5650
Anti Nicotine Therapies (2010 - 2015) Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market.	October 2010	$ 4650
Opportunity Analysis of H1N1 (swine flu) Vaccination Market The increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market.	October 2010	$ 4650
Diabetes Market (Devices and Drugs) Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share	October 2010	$ 4650
Top 25 OTC Drugs Market (2010 - 2015) Over the counter drugs can be broadly segmented as analgesics, topical medicines, cough and cold preparations, indigestion preparations, medicated skin products, first aid kits, plaster and bandages, traditional medicines and vitamins and minerals. Among all the OTC drugs cough and cold preparations lead the OTC healthcare market with almost 18% of market share. Johnson& Johnson, GlaxoSmithKline Plc and Novartis AG are the leading players of global OTC market.	October 2010	$ 4650